- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
S04-04 OA. HIV-specific responses induced by anti-CD40 targeting antibodies ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Urheber
-
Loof, N.
- Beteiligte Personen und Organisationen
-
Montes, M.
Flamar, A.
Zurawski, G.
Cobb, A.
Plants, J.
King, B.
Zurawski, S.
Sloan, L.
Levy, Y.
Banchereau, J.
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-O46
- URN
-
urn:nbn:de:1111-2016080710385
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Loof, N.
- Montes, M.
- Flamar, A.
- Zurawski, G.
- Cobb, A.
- Plants, J.
- King, B.
- Zurawski, S.
- Sloan, L.
- Levy, Y.
- Banchereau, J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?
FcγRs and their relevance for the activity of anti-CD40 antibodies
Chronic Immune Activation in HIV-1 Infection Contributes to Reduced Interferon Alpha Production via Enhanced CD40:CD40 Ligand Interaction
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Mechanismen der Aktivierung von CD40 durch monoklonale Antikörper und löslichen CD40 Liganden und der Nachweis von löslichem CD40 in vivo, einem möglichen Regulator der CD40-CD40 Ligand Interaktion
Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy
Targeting antibodies into the living cell
P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
An Adaptable Antibody‐Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?
FcγRs and their relevance for the activity of anti-CD40 antibodies
Chronic Immune Activation in HIV-1 Infection Contributes to Reduced Interferon Alpha Production via Enhanced CD40:CD40 Ligand Interaction
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Mechanismen der Aktivierung von CD40 durch monoklonale Antikörper und löslichen CD40 Liganden und der Nachweis von löslichem CD40 in vivo, einem möglichen Regulator der CD40-CD40 Ligand Interaktion
Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy
Targeting antibodies into the living cell
P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
An Adaptable Antibody‐Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies
Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?
FcγRs and their relevance for the activity of anti-CD40 antibodies
Chronic Immune Activation in HIV-1 Infection Contributes to Reduced Interferon Alpha Production via Enhanced CD40:CD40 Ligand Interaction
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Mechanismen der Aktivierung von CD40 durch monoklonale Antikörper und löslichen CD40 Liganden und der Nachweis von löslichem CD40 in vivo, einem möglichen Regulator der CD40-CD40 Ligand Interaktion
Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy
Targeting antibodies into the living cell
P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
An Adaptable Antibody‐Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies